Back to Search
Start Over
Catalytic evaluation and in vitro bacterial inactivation of graphitic carbon nitride/carbon sphere doped bismuth oxide quantum dots with evidential in silico analysis.
- Source :
-
RSC advances [RSC Adv] 2023 Aug 23; Vol. 13 (36), pp. 25305-25315. Date of Electronic Publication: 2023 Aug 23 (Print Publication: 2023). - Publication Year :
- 2023
-
Abstract
- Herein, Bi <subscript>2</subscript> O <subscript>3</subscript> quantum dots (QDs) have been synthesized and doped with various concentrations of graphitic carbon nitride (g-C <subscript>3</subscript> N <subscript>4</subscript> ) and a fixed amount of carbon spheres (CS) using a co-precipitation technique. XRD analysis confirmed the presence of monoclinic structure along the space group P 2 <subscript>1</subscript> / c and C 2/ c . Various functional groups and characteristic peaks of (Bi-O) were identified using FTIR spectra. QDs morphology of Bi <subscript>2</subscript> O <subscript>3</subscript> showed agglomeration with higher amounts of g-C <subscript>3</subscript> N <subscript>4</subscript> by TEM analysis. HR-TEM determined the variation in the d -spacing which increased with increasing dopants. These doping agents were employed to reduce the exciting recombination rate of Bi <subscript>2</subscript> O <subscript>3</subscript> QDs by providing more active sites which enhance antibacterial activity. Notably, (6 wt%) g-C <subscript>3</subscript> N <subscript>4</subscript> /CS-doped Bi <subscript>2</subscript> O <subscript>3</subscript> exhibited considerable antimicrobial potential in opposition to E. coli at higher values of concentrations relative to ciprofloxacin. The (3 wt%) g-C <subscript>3</subscript> N <subscript>4</subscript> /CS-doped Bi <subscript>2</subscript> O <subscript>3</subscript> exhibits the highest catalytic potential (97.67%) against RhB in a neutral medium. The compound g-C <subscript>3</subscript> N <subscript>4</subscript> /CS-Bi <subscript>2</subscript> O <subscript>3</subscript> has been suggested as a potential inhibitor of β-lactamase <subscript> E. coli </subscript> and DNA gyrase <subscript> E. coli </subscript> based on the findings of a molecular docking study that was in better agreement with in vitro bactericidal activity.<br />Competing Interests: No conflict of interest.<br /> (This journal is © The Royal Society of Chemistry.)
Details
- Language :
- English
- ISSN :
- 2046-2069
- Volume :
- 13
- Issue :
- 36
- Database :
- MEDLINE
- Journal :
- RSC advances
- Publication Type :
- Academic Journal
- Accession number :
- 37622014
- Full Text :
- https://doi.org/10.1039/d3ra04664h